Company Filing History:
Years Active: 2015-2016
Title: Arthur Yeung: Innovator in Phosphatidylinositol 3-Kinase Inhibitors
Introduction
Arthur Yeung is a notable inventor based in Redmond, WA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of phosphatidylinositol 3-kinase (PI3K) inhibitors. With a total of 2 patents to his name, Yeung's work is paving the way for advancements in medical treatments.
Latest Patents
Yeung's latest patents focus on phosphatidylinositol 3-kinase inhibitors. These patents provide detailed formulations of PI3K inhibitors, which are useful for treating conditions mediated by various PI3K isoforms, including PI3Kδ. The disclosures include pharmaceutical compositions that incorporate these compounds and methods for their application in medical treatments.
Career Highlights
Arthur Yeung is currently employed at Gilead Calistoga LLC, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments that address critical health issues.
Collaborations
Yeung collaborates with esteemed colleagues such as Jerry B Evarts and Leena Patel. Their combined expertise enhances the research and development efforts at Gilead Calistoga LLC.
Conclusion
Arthur Yeung is a prominent figure in the field of pharmaceutical innovation, particularly known for his work on PI3K inhibitors. His contributions are vital for advancing treatment options in medicine.